Skip to content

Advertisement

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Circulating microRNA’s as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology

  • K. Sartorius1, 2, 3,
  • B. Sartorius1, 3Email author,
  • A. Kramvis4,
  • E. Singh5,
  • A. Turchinovich6, 7,
  • B. Burwinkel6,
  • T. Madiba3 and
  • C. A. Winkler8
BMC Cancer201717:894

https://doi.org/10.1186/s12885-017-3915-z

Received: 6 December 2016

Accepted: 14 December 2017

Published: 28 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
6 Dec 2016 Submitted Original manuscript
19 Feb 2017 Author responded Author comments - Kurt Sartorius
Resubmission - Version 2
19 Feb 2017 Submitted Manuscript version 2
14 Oct 2017 Author responded Author comments - Kurt Sartorius
Resubmission - Version 3
14 Oct 2017 Submitted Manuscript version 3
2 Dec 2017 Author responded Author comments - Kurt Sartorius
Resubmission - Version 4
2 Dec 2017 Submitted Manuscript version 4
Publishing
14 Dec 2017 Editorially accepted
28 Dec 2017 Article published 10.1186/s12885-017-3915-z

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa
(2)
Faculty of Commerce, Law and Management, University of the Witwatersrand, Johannesburg, South Africa
(3)
UKZN Gastrointestinal Cancer Research Centre (GICRC), Durban, South Africa
(4)
Hepatitis Virus Diversity Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
(5)
South African National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa
(6)
Molecular Epidemiology Group, German Cancer Research Centre, Heidelberg, Germany
(7)
SciBerg e.Kfm, Mannheim, Germany
(8)
Basic Research Laboratory, Centre for Cancer Research, National Cancer Institute, Leidos Biomedical Research, Inc. Frederick Nat. Lab. for Cancer Research, Frederick, USA

Advertisement